Genomic Surveillance of SARS-CoV-2 in Malaysia during the Era of Endemic COVID-19

被引:4
|
作者
Lee, Tze Yan [1 ]
Lim, Wai Feng [2 ]
Ang, Geik Yong [3 ]
Yu, Choo Yee [4 ]
机构
[1] Perdana Univ, Sch Liberal Arts Sci & Technol PUScLST, Kuala Lumpur 50490, Malaysia
[2] Sunway Med Ctr, Bandar Sunway, Subang Jaya 47500, Malaysia
[3] Univ Teknol MARA, Fac Sports Sci & Recreat, Shah Alam 40450, Malaysia
[4] Univ Putra Malaysia, Inst Biosci, Lab Vaccine & Biomol, Serdang 43400, Malaysia
来源
LIFE-BASEL | 2023年 / 13卷 / 08期
关键词
COVID-19; endemic; BA.5; XBB; subvariants; VOI; Malaysia; Omicron; waves; VUM;
D O I
10.3390/life13081644
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
On 5 May 2023, WHO declared the end of coronavirus disease 2019 (COVID-19) as a public health emergency of international concern. However, the risk of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants causing rapid and high surges in cases and deaths remained. In Malaysia, five COVID-19 waves during the pandemic phase were well characterized, but similar studies focusing on the endemic phase were lacking. Hence, we retrieved 14,965 SARS-CoV-2 genomic sequences from the GISAID EpiCoV database for clade, lineage, and phylogenetic analysis in order to provide an insight into the population dynamics of SARS-CoV-2 that circulated in Malaysia from June 2022 to April 2023. The dominance of the Omicron variants was observed, and two new waves of infections driven by BA.5.2 and XBB.1, respectively, were detected. Data as of April 2023 also pointed to a possible eighth wave driven by XBB.1.9. Although new variants associated with higher transmissibility were behind the multiple surges, these subsequent waves had lower intensities as compared to the fourth and fifth waves. The on-going circulation and evolution of SARS-CoV-2 mean that COVID-19 still poses a serious threat, necessitating active genomic surveillance for early warning of potential new variants of concern.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] SARS-CoV-2 reinfection: "New baseline" imaging concept in the era of COVID-19
    Katal, Sanaz
    Myers, Lee
    Gholamrezanezhad, Ali
    CLINICAL IMAGING, 2021, 78 : 142 - 145
  • [22] Effectiveness of COVID-19 Vaccines and Antiviral Therapies in the Era of SARS-CoV-2 Variants
    Unuvar, Gamze Kalin
    Rello, Jordi
    Alp, Emine
    ERCIYES MEDICAL JOURNAL, 2023, 45 (01) : 1 - 7
  • [23] SARS-CoV-2 and COVID-19: A Narrative Review
    Blann, A. D.
    Heitmar, R.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2022, 79
  • [24] SARS-CoV-2 (COVID-19) and cystic fibrosis
    Stanton, Bruce A.
    Hampton, Thomas H.
    Ashare, Alix
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2020, 319 (03) : L408 - L415
  • [25] Impact of SARS-CoV-2/COVID-19 on the placenta
    Menter, T.
    Tzankov, A.
    Bruder, E.
    PATHOLOGE, 2021, 42 (06): : 591 - 597
  • [26] A Strategic Framework of SARS-CoV-2 Genomic Surveillance in Bangladesh
    Jubair, Mohammad
    Hossain, Md. Mobarok
    Begum, Mst. Noorjahan
    Moon, Shovan Basak
    Islam, Shahriar
    Karim, Md. Yeasir
    Rahman, Sezanur
    Khan, Manjur H.
    Habib, Mohammad Tanbir
    Shirin, Tahmina
    Qadri, Firdausi
    Rahman, Mustafizur
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2024, 18 (10)
  • [27] SARS-CoV-2: Remarks on the COVID-19 Pandemic
    Egbert Piasecki
    Archivum Immunologiae et Therapiae Experimentalis, 2020, 68
  • [28] SARS-CoV-2 Infection and COVID-19 in Children
    Waghmare, Alpana
    Hijano, Diego R.
    CLINICS IN CHEST MEDICINE, 2023, 44 (02) : 359 - 371
  • [29] COVID-19: implications of SARS-CoV-2 in Colombia
    Almeida-Espinosa, Alexander
    Sarmiento-Ardila, Jorge A.
    GACETA MEDICA DE MEXICO, 2020, 156 (04): : 334 - 338
  • [30] Overview of SARS-CoV-2 and COVID-19 Vaccine
    Alhaibil, Nada Abdullah
    BAHRAIN MEDICAL BULLETIN, 2021, 43 (02) : 511 - 515